Article Information
History
- August 18, 2021.
Article Versions
- You are currently viewing Version 1 of this article (August 18, 2021 - 12:12).
- Version 2 (August 20, 2021 - 08:43).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Megan Rutter1,2,*,
- Peter C. Lanyon1,2,3,4,
- Matthew J. Grainge1,
- Richard Hubbard1,4,
- Emily Peach1,
- Mary Bythell3,
- Peter Stilwell3,
- Jeanette Aston3,
- Sarah Stevens3 and
- Fiona A. Pearce1,2,3,4
- 1Department of Population and Lifespan Sciences, School of Medicine, University of Nottingham, Nottingham, UK
- 2Department of Rheumatology, Nottingham University Hospitals NHS Trust, Nottingham, UK
- 3National Congenital Anomaly and Rare Disease Registration Service, National Disease Registration Service, Public Health England, UK
- 4National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham, UK
- ↵*Corresponding author:
Megan Rutter, Clinical Sciences Building, City Hospital Campus, University of Nottingham, NG5 1PB. megan.rutter{at}nottingham.ac.uk
Posted August 18, 2021.
COVID-19 Infection, Admission and Death Amongst People with Rare Autoimmune Rheumatic Disease in England. Results from the RECORDER Project
